These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26947555)

  • 1. Successful treatment of osteonecrosis-induced fractured mandible with teriparatide therapy: A case report.
    Yao M; Shimo T; Ono Y; Obata K; Yoshioka N; Sasaki A
    Int J Surg Case Rep; 2016; 21():151-3. PubMed ID: 26947555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Osteonecrosis of the Jaw.
    Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S
    J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for managing medication-related osteonecrosis of the jaw.
    Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O; Peter JU
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012432. PubMed ID: 35866376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The recombinant human parathyroid hormone, teriparatide as an alternative remedy for the medication-related osteonecrosis of the jaw].
    Gera I; Szücs N
    Orv Hetil; 2023 Sep; 164(36):1406-1415. PubMed ID: 37695713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide for the Treatment of Medication-Related Osteonecrosis of the Jaw.
    Chopra K; Malhan N
    Am J Ther; 2020 Jun; 28(4):e469-e477. PubMed ID: 32618592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
    Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
    Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
    Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
    Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Medication-Related Osteonecrosis of the Jaw Around the Dental Implant With a Once-Weekly Teriparatide: A Case Report and Literature Review.
    Kim JY; Park JH; Jung HD; Jung YS
    J Oral Implantol; 2019 Oct; 45(5):403-407. PubMed ID: 31429640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy.
    Lee JJ; Cheng SJ; Jeng JH; Chiang CP; Lau HP; Kok SH
    Head Neck; 2011 Sep; 33(9):1366-71. PubMed ID: 20310042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis.
    Iwamoto J; Yago K; Sato Y; Matsumoto H
    Clin Drug Investig; 2012 Aug; 32(8):547-53. PubMed ID: 22734599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw.
    Zandi M; Dehghan A; Amini P; Doulati S; Rezaeian L
    Clin Oral Investig; 2019 Nov; 23(11):3987-3993. PubMed ID: 30715621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan.
    Morishita K; Yamada SI; Kawakita A; Hashidume M; Tachibana A; Takeuchi N; Ohbayashi Y; Kanno T; Yoshiga D; Narai T; Sasaki N; Shinohara H; Uzawa N; Miyake M; Tominaga K; Kodani I; Umeda M; Kurita H
    J Orthop Sci; 2020 Nov; 25(6):1079-1083. PubMed ID: 32111549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Teriparatide and Recombinant Human Bone Morphogenetic Protein-2 for Regenerative Approach to Medication-Related Osteonecrosis of the Jaw: A Preliminary Study.
    Jung J; Yoo HY; Kim GT; Lee JW; Lee YA; Kim DY; Kwon YD
    J Bone Miner Res; 2017 Dec; 32(12):2445-2452. PubMed ID: 28815779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective ancillary role and long-term course of daily or weekly teriparatide treatment on refractory medication-related osteonecrosis of the jaw: a clinical case series.
    Yoshiga D; Yoshioka I; Habu M; Sasaguri M; Tominaga K
    Br J Oral Maxillofac Surg; 2022 Jun; 60(5):604-609. PubMed ID: 34996629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
    Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
    Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive recombinant human parathyroid hormone agents for the treatment of medication-related osteonecrosis of the jaw: a report of three cases.
    Choi SY; Yoon D; Kim KM; Kim SJ; Kim HY; Kim JW; Park JH
    J Korean Assoc Oral Maxillofac Surg; 2024 Apr; 50(2):103-109. PubMed ID: 38693133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
    Sim IW; Borromeo GL; Tsao C; Hardiman R; Hofman MS; Papatziamos Hjelle C; Siddique M; Cook GJR; Seymour JF; Ebeling PR
    J Clin Oncol; 2020 Sep; 38(26):2971-2980. PubMed ID: 32614699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of bone regeneration of a necrotic mandible with pathologic fracture in an elderly hemodialysis patient with medication-related osteonecrosis of the jaw: a case report and review of the literature.
    Yoshizawa K; Moroi A; Iguchi R; Takayama A; Goto J; Takayama Y; Ueki K
    J Med Case Rep; 2021 Dec; 15(1):608. PubMed ID: 34937568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of drug holiday on preventing medication-related osteonecrosis of the jaw in osteoporotic rat model.
    Zhu WY; Yang WF; Wang L; Lan X; Tao ZY; Guo J; Xu J; Qin L; Su YX
    J Orthop Translat; 2023 Mar; 39():55-62. PubMed ID: 36721766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model.
    Liu J; Mattheos N; Deng C; Su C; Wang Z; Luo N; Tang H
    J Periodontol; 2021 Jan; 92(1):149-158. PubMed ID: 32281098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.